$OVID Ovid Therapeutics Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ovid Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ovid Therapeutics Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Ovid Therapeutics Inc. for free.
IRS Number: 465270895
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: OVID
Company Address: 1460 BROADWAY SUITE 15044 NEW YORK 10036
Phone number: 646-661-7661
Ovid Therapeutics Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10 2021 | OVID | Ovid Therapeutics ... | Rona Jeffrey A | Chief Business Offi ... | Option Exercise | A | 4.42 | 100,000 | 442,000 | 100,000 | |
| May 18 2021 | OVID | Ovid Therapeutics ... | Bernstein Karen | Director | Option Exercise | A | 3.67 | 1,750 | 6,423 | 1,750 | |
| Apr 29 2021 | OVID | Ovid Therapeutics ... | Perone Thomas Michael | General Counsel, Se ... | Option Exercise | A | 3.66 | 44,000 | 161,040 | 44,000 | |
| Apr 29 2021 | OVID | Ovid Therapeutics ... | Tardio Jason | Chief Commercial Of ... | Option Exercise | A | 3.66 | 44,000 | 161,040 | 44,000 | |
| Feb 08 2021 | OVID | Ovid Therapeutics ... | Tardio Jason | Chief Commercial Of ... | Option Exercise | A | 7.40 | 75,000 | 555,000 | 75,000 | |
| Dec 21 2020 | OVID | Ovid Therapeutics ... | Tardio Jason | Chief Commercial Of ... | Option Exercise | A | 2.82 | 175,000 | 493,500 | 175,000 | |
| Dec 21 2020 | OVID | Ovid Therapeutics ... | Perone Thomas Michael | General Counsel, Se ... | Option Exercise | A | 2.82 | 175,000 | 493,500 | 175,000 | |
| Dec 21 2020 | OVID | Ovid Therapeutics ... | Rona Jeffrey A | Chief Business Offi ... | Option Exercise | A | 2.82 | 175,000 | 493,500 | 175,000 | |
| Dec 21 2020 | OVID | Ovid Therapeutics ... | Rakhit Amit | President and CMO | Option Exercise | A | 2.82 | 200,000 | 564,000 | 200,000 | |
| Dec 21 2020 | OVID | Ovid Therapeutics ... | Rakhit Amit | President and CMO | Option Exercise | A | 2.82 | 200,000 | 564,000 | 200,000 | |
| Dec 21 2020 | OVID | Ovid Therapeutics ... | LEVIN JEREMY M | CEO | Option Exercise | A | 2.82 | 650,000 | 1,833,000 | 650,000 | |
| Dec 21 2020 | OVID | Ovid Therapeutics ... | Haasner Dirk | SVP, Global Regulat ... | Option Exercise | A | 2.82 | 100,000 | 282,000 | 100,000 | |
| Dec 21 2020 | OVID | Ovid Therapeutics ... | Daly Timothy | EVP,Finance & Corp. ... | Option Exercise | A | 2.82 | 125,000 | 352,500 | 125,000 | |
| Oct 13 2020 | OVID | Ovid Therapeutics ... | Rona Jeffrey A | Chief Business Offi ... | Option Exercise | A | 5.65 | 20,000 | 113,000 | 20,000 | |
| Oct 13 2020 | OVID | Ovid Therapeutics ... | Haasner Dirk | SVP, Global Regulat ... | Option Exercise | A | 5.65 | 20,000 | 113,000 | 20,000 |